New and emerging therapies for the treatment of rheumatoid arthritis

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


The introduction of tumor necrosis factor (TNF) inhibitors in the late 1990s significantly changed the therapeutic approach for rheumatoid arthritis (RA). With the approval of subsequent TNF inhibitors as well as other biologic agents effective in the management of RA, the treatment paradigm has become increasingly complex. This review examines the current literature regarding the efficacy and toxicity of these and other new anti-rheumatic therapies and discusses effective therapeutic strategies for their use.

Original languageEnglish (US)
Pages (from-to)35-43
Number of pages9
JournalOpen Access Rheumatology: Research and Reviews
StatePublished - 2010


  • Abatacept
  • Adalimumab
  • Biologics
  • Certolizumab
  • Dmards
  • Etancercept
  • Golimumab
  • Infliximab
  • Rituximab
  • Tocilizumab
  • Tumor necrosis factor inhibitors

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'New and emerging therapies for the treatment of rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this